Global influenza diagnostics industry set to reach $ 1.1 billion by 2026 – ResearchAndMarkets.com

DUBLIN – (COMMERCIAL THREAD)–The “Influenza diagnostics market by product (test kits, instruments), type of test (traditional (RIDT, viral culture, serological), molecular (PCR, INAAT-NASBAT, TMABAS), end user (diagnostic laboratories, hospitals) , clinics), region- Global forecast to 2026 “ report was added to ResearchAndMarkets.com offer.

The global influenza diagnostics market is expected to reach $ 1.1 billion by 2026, up from $ 0.8 billion in 2021, at a CAGR of 7.7% during the forecast period.

The growth of the market is driven by factors such as the growth of influenza research for diagnostic technologies, the increasing demand for rapid disease diagnosis, and the increasing prevalence of influenza. On the other hand, rising healthcare costs, variability in the sensitivity and specificity of the tests are the major factors hampering the growth of this market.

The test kits and reagents segment accounted for the highest growth rate of the influenza diagnostics market, by product, during the forecast period.

The influenza diagnostics market is segmented into test kits and reagents, instruments, and other product-based products. In 2020, the test kits and reagents segment recorded the highest growth rate of the influenza diagnostics market. The increasing prevalence of influenza and the increasing demand for rapid disease diagnosis are major factors contributing to the growth of this segment.

Molecular diagnostic testing segment accounted for the highest growth rate of the influenza diagnostic market, by test type, during the forecast period

The influenza diagnostics market is segmented into molecular diagnostic tests and traditional diagnostic tests based on the type of test. In 2020, the molecular diagnostic testing segment accounted for the highest growth rate of the influenza diagnostics market. The growth of influenza research for diagnostic technologies and the increasing demand for rapid disease diagnosis are major factors contributing to the growth of this segment.

The diagnostic lab segment had the highest CAGR

Based on the end user, the influenza diagnostics market is segmented into diagnostic laboratories, hospitals and clinics and other end users. In 2020, the hospital and clinic segment had the highest CAGR. This can be attributed to the increasing demand for rapid diagnosis of diseases and the increasing prevalence of influenza.

Asia-Pacific: Fastest Growing Region in Influenza Diagnostics Market

The global influenza diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. The Asia-Pacific region is expected to register the highest CAGR during the forecast period. Factors such as increasing demand for rapid disease diagnosis and growth of influenza research for diagnostic technologies are driving the growth of influenza diagnosis market in this region.

Market dynamics

Conductors

• Growing prevalence of influenza

• Growth of influenza research for diagnostic technologies

• Growing demand for rapid disease diagnosis

Constraints

• Variabilities in test sensitivity and specificity

• Rising health care costs

Opportunities

• Advances in genomics and proteomics technologies

• Significant growth prospects in developing countries

Challenges

• Lack of qualified professionals

• Strict regulatory frameworks

Companies mentioned

• Abbott Laboratories, Inc

• Altona Diagnostics GmbH

• B Blackbio Biotech India Ltd

• Becton, Dickinson and company

• Biomérieux SA

• Coris Bioconcept Sprl

• Danaher Company

• Diasorin Sa

• Élitech Group

• F Hoffmann-La Roche AG

• Genmark Diagnosis, Inc

• Genome Diagnostics Pvt Ltd

• Germaine Laboratories, Inc

• Hologic, Inc

• Luminex Company

• Mast Group Ltd.

• Meridian bioscience

• Quidel Corporation

• Biomedical Corp response

• Scientific SA, Ltd

• Sekisui diagnosis

• Siemens Healthineers

• Tauns Laboratories, Inc

• Tecan Trading AG

• Thermo Fisher Scientific, Inc

For more information on this report, visit https://www.researchandmarkets.com/r/u0834p